Stock Analysis

3 Growth Companies With High Insider Ownership On The KRX

KOSDAQ:A101490
Source: Shutterstock

The South Korea stock market recently halted a three-day winning streak, with the KOSPI index resting just above the 2,700-point plateau. Despite this slight dip, optimism remains high due to positive global forecasts and support from financial shares and automobile producers. In such a fluctuating market environment, growth companies with high insider ownership can offer stability and potential for long-term gains. Here are three such stocks on the KRX that stand out for their promising growth prospects and significant insider investment.

Top 10 Growth Companies With High Insider Ownership In South Korea

NameInsider OwnershipEarnings Growth
People & Technology (KOSDAQ:A137400)16.5%35.6%
Seojin SystemLtd (KOSDAQ:A178320)30.9%52.1%
Bioneer (KOSDAQ:A064550)17.5%89.7%
Global Tax Free (KOSDAQ:A204620)21.4%78.5%
Oscotec (KOSDAQ:A039200)26.3%114.7%
Park Systems (KOSDAQ:A140860)33%37.5%
Vuno (KOSDAQ:A338220)19.5%110.9%
HANA Micron (KOSDAQ:A067310)21.3%97.4%
UTI (KOSDAQ:A179900)33.1%122.7%
Techwing (KOSDAQ:A089030)18.7%77.8%

Click here to see the full list of 92 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Let's take a closer look at a couple of our picks from the screened companies.

S&S Tech (KOSDAQ:A101490)

Simply Wall St Growth Rating: ★★★★★☆

Overview: S&S Tech Corporation manufactures and sells blank masks worldwide, with a market cap of ₩576.23 billion.

Operations: S&S Tech Corporation generates revenue from the manufacturing and sale of blank masks globally.

Insider Ownership: 22.6%

S&S Tech Corporation has recently announced a share repurchase program worth KRW 10 billion to improve shareholder value and stabilize the stock price, set to expire on November 8, 2024. The company has shown strong growth with earnings increasing by 15.1% over the past year and is expected to see significant annual profit growth of 36.67% over the next three years, outpacing market expectations. Revenue is forecasted to grow at an impressive rate of 30.6% per year, well above the market average of 10.7%.

KOSDAQ:A101490 Earnings and Revenue Growth as at Aug 2024
KOSDAQ:A101490 Earnings and Revenue Growth as at Aug 2024

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc., a biotechnology company, specializes in creating long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars with a market cap of ₩16.73 billion.

Operations: The company generates revenue primarily from its biotechnology segment, amounting to ₩90.79 million.

Insider Ownership: 26.6%

ALTEOGEN Inc. is forecast to achieve profitability within three years, with earnings projected to grow at 99.46% annually and revenue at 64.2% per year, significantly outpacing the South Korean market average. Despite recent shareholder dilution and a highly volatile share price, the company trades at 75.6% below its estimated fair value. The recent approval of Tergase® by Korea's MFDS marks a crucial step in expanding product applications and transitioning ALTEOGEN into a commercial-stage company.

KOSDAQ:A196170 Ownership Breakdown as at Aug 2024
KOSDAQ:A196170 Ownership Breakdown as at Aug 2024

HYBE (KOSE:A352820)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: HYBE Co., Ltd. operates in music production, publishing, and artist development and management with a market cap of ₩7.36 trillion.

Operations: HYBE's revenue segments include Label (₩1.28 billion), Platform (₩361.12 million), and Solution (₩1.24 billion).

Insider Ownership: 32.5%

HYBE Co., Ltd. is trading 22.5% below its estimated fair value, with earnings forecast to grow 42.47% annually, outpacing the South Korean market average of 28.8%. Despite a significant drop in net income for Q2 2024 compared to the previous year, revenue growth remains positive at 14% per year. However, low return on equity (9.9%) in three years and large one-off items impacting financial results are concerns for investors focusing on quality earnings and sustainable growth.

KOSE:A352820 Earnings and Revenue Growth as at Aug 2024
KOSE:A352820 Earnings and Revenue Growth as at Aug 2024

Summing It All Up

Looking For Alternative Opportunities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com